BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2852169)

  • 1. Safety & efficacy of Japanese encephalitis vaccine produced in India.
    Rao Bhau LN; Singh G; Gowal D; Saxena SN; Kobayashi M; Oya A; Yoshioka I
    Indian J Med Res; 1988 Oct; 88():301-7. PubMed ID: 2852169
    [No Abstract]   [Full Text] [Related]  

  • 2. A field trial of Japanese encephalitis vaccine produced in Thailand.
    Rojanasuphot S; Charoensuk O; Kitprayura D; Likityingvara C; Limpisthien S; Boonyindee S; Jivariyavej V; Ugchusak K
    Southeast Asian J Trop Med Public Health; 1989 Dec; 20(4):653-4. PubMed ID: 2561722
    [No Abstract]   [Full Text] [Related]  

  • 3. Japanese encephalitis. Inactivated Japanese encephalitis virus vaccine.
    Wkly Epidemiol Rec; 1994 Apr; 69(16):113-8. PubMed ID: 8003406
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study of protection by Japanese encephalitis (JE) vaccine against a Japanese strain and an Indian strain of JE virus.
    Das BC; Chakrabarti SK; Sarkar JK; Mukherjee KK
    Indian J Pathol Microbiol; 1976 Oct; 19(4):239-43. PubMed ID: 191395
    [No Abstract]   [Full Text] [Related]  

  • 5. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japanese encephalitis immunization in South Korea: past, present, and future.
    Sohn YM
    Emerg Infect Dis; 2000; 6(1):17-24. PubMed ID: 10653564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study.
    Luo D; Yin H; Xili L; Song J; Wang Z
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):643-6. PubMed ID: 7667706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune status of volunteers one year after administration of Japanese encephalitis vaccine produced in India.
    Saxena SN; Bhau LN; Singh G; Gowal D; Sood YK; Misra CN; Das BK
    Indian J Med Res; 1989 Nov; 89():362-7. PubMed ID: 2559892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological response to Japanese encephalitis vaccine in a group of school children in South Arcot district of Tamil Nadu.
    Mohan Rao CV; Risbud AR; Dandawate CN; Umarani UB; Ayachit VM; Rodrigues FM; Pavri KM
    Indian J Med Res; 1993 Mar; 97():53-9. PubMed ID: 8505074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
    Konishi E; Yamaoka M; Kurane I; Mason PW
    Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of current Japanese encephalitis vaccine on different strains of Japanese encephalitis virus.
    Okuno Y; Okamoto Y; Yamada A; Baba K; Yabuuchi H
    Vaccine; 1987 Jun; 5(2):128-32. PubMed ID: 3037813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Advisory Committee on Immunization (NACI). Statement on Japanese encephalitis vaccine.
    Can Commun Dis Rep; 1993 Oct; 19(19):160-4. PubMed ID: 8251988
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of effectiveness of mouse brain inactivated Japanese encephalitis vaccine produced in India.
    Gowal D; Tahlan AK
    Indian J Med Res; 1995 Dec; 102():267-71. PubMed ID: 8557319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal boosting of Japanese encephalitis vaccination.
    Kitchener S; Baade L; Brennan L; Nasveld P
    J Travel Med; 2004; 11(3):182-3. PubMed ID: 15710061
    [No Abstract]   [Full Text] [Related]  

  • 16. Further experience with Japanese encephalitis vaccine.
    Sanchez JL; Hoke CH; McCown J; DeFraites RF; Takafuji ET; Diniega BM; Pang LW
    Lancet; 1990 Apr; 335(8695):972-3. PubMed ID: 1970043
    [No Abstract]   [Full Text] [Related]  

  • 17. A special note on Japanese encephalitis vaccine.
    Lamabadusuriya SP
    Ceylon Med J; 1993 Sep; 38(3):103-4. PubMed ID: 7828224
    [No Abstract]   [Full Text] [Related]  

  • 18. Japanese encephalitis vaccine and adverse effects among travellers.
    Robinson HC; Russell ML; Csokonay WM
    Can Dis Wkly Rep; 1991 Aug; 17(32):173-4, 177. PubMed ID: 1657420
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection against Japanese encephalitis by inactivated vaccines.
    Hoke CH; Nisalak A; Sangawhipa N; Jatanasen S; Laorakapongse T; Innis BL; Kotchasenee S; Gingrich JB; Latendresse J; Fukai K
    N Engl J Med; 1988 Sep; 319(10):608-14. PubMed ID: 2842677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the reactogenicity and immunogenicity of new Soviet and commercial vaccines for preventing Japanese encephalitis].
    Sumarovkov AA; Grachev VP; Kharazian EG; Shkol'nik RIa; Vorob'eva MS
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):74-9. PubMed ID: 6314716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.